Fat cell hormone restrains liver tumours in mice US researchers find

Fat cell hormone restrains liver tumours in mice US researchers find

A hormone secreted by fat cells can restrain the growth of liver tumours in mice, according to a new study by US researchers from the University of Michigan Life Sciences Institute.

The findings offer a proof-of-concept for developing therapies against hepatocellular carcinoma, the most common form of liver cancer.

Jiandie Lin, a faculty member at the U-M Life Sciences Institute and the study’s senior author, and his team use mice as a model to study how molecular and cellular changes are affected by non-alcoholic fatty liver disease, and how these changes consequently lead to the progression of this disease. While it begins as a relatively benign accumulation of fat in the liver, the disorder can develop into non-alcoholic steatohepatitis, or NASH, which increases the risk for liver cancer.

The liver contains scores of different cell types, including various immune cells. Using single-cell RNA sequencing, a technology for probing gene expression of individual cells within complex tissues, Lin and his team previously constructed a liver cell atlas and a blueprint of intercellular signalling in healthy and NASH mouse livers.

“Liver cancer in NASH patients is different from cancers caused by viral hepatitis, in that it often develops in the absence of liver cirrhosis,” said Lin. “We suspect that different disease mechanisms may be engaged in NASH-related liver cancer.”

Lin and his colleagues observed changes in two types of immune cells in particular that appear to contribute to the development of HCC. In mouse livers with NASH, T cells – the immune cells that normally fight infected or damaged cells, such as cancerous cells – showed hallmarks of functional impairments. At the same time, the team found that a second type of immune cell, called macrophages, acquired molecular features typically associated with cancers.

“These changes we saw in macrophages and T cells resemble the tumour microenvironment, but they are happening even before any cancer becomes apparent,” he added. “It gives us a hint that maybe these changes in the liver microenvironment could provide fertile ground for liver cancer cells to appear and grow. It almost looks like the liver, once it develops NASH, is already preparing for cancer cells to thrive.

“A lot of studies on liver cancer focus on the cancerous liver cells themselves: how they proliferate and how they evade the immune system, but our findings break out of this liver-centred framework, showing a fat-derived hormone could actually reprogramme the liver environment and have a very big impact on liver cancer development.”

The research appears in Cell Metabolism.

Leave a reply

Your email address will not be published. Required fields are marked *

Aether: Issue 3 Feb 2023

Aether: Issue 2 Nov 2022

Aether: Issue 1 Aug 2022

Subscribe for free

Latest Testimonial

What a beautiful motto: Discoveries must be read and not just published. When I was contacted by Aether as a new digital service to share scientific and technological insights I had my doubts that this was really going to be according to what I call the “open source & makers’ spirit”: knowledge should be free and it is there to be shared.

Well, Aether is faithful to its motto and shares discoveries freely. It has been a pleasure to collaborate for the interview and subsequent article. It has been greatly self satisfying to see how the interview was professionally and truthfully redacted and then published. Sharing thoughts and sparks for discussions is fundamental to the progress of society. Your journal offers clarity and brevity and I believe it provides the sparks to ignite any reader whether academic or not into action.

Dr Maria-Cristina Ciocci
Co-founder and Manager of non-profit organisation De Creative STEM,GirlsInSTEM